HIND
Price
$1.88
Change
-$0.02 (-1.05%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
14.25M
39 days until earnings call
Intraday BUY SELL Signals
PHAT
Price
$6.92
Change
-$0.58 (-7.73%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
594.62M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HIND vs PHAT

HIND vs PHAT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
HIND vs. PHAT commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and PHAT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HIND with price predictions
Oct 15, 2026

HIND saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for HIND moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 19 similar instances where the indicator exited the overbought zone. In 18 of the 19 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIND as a result. In 84 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for HIND turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 38 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for HIND entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIND's RSI Oscillator exited the oversold zone, 38 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +3.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIND advanced for three days, in 142 of 174 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

HIND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.356) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (108.696) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. HIND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for PHAT with price predictions
Oct 15, 2026

PHAT sees its Stochastic Oscillator recovers from oversold territory

On October 08, 2026, the Stochastic Oscillator for PHAT moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In 58 of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PHAT's RSI Oscillator exited the oversold zone, 26 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on PHAT as a result. In 64 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for PHAT just turned positive on October 08, 2026. Looking at past instances where PHAT's MACD turned positive, the stock continued to rise in 43 of 47 cases over the following month. The odds of a continued upward trend are 90%.

Following a +7.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where PHAT advanced for three days, in 243 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

PHAT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for PHAT entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (25.575) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (2.511) is also within normal values, averaging (437.542).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. PHAT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
HIND vs PHAT: Fundamental Ratings
HIND
PHAT
OUTLOOK RATING
1..100
3228
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
7784
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5014

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HIND's Valuation (40) in the null industry is in the same range as PHAT (69). This means that HIND’s stock grew similarly to PHAT’s over the last 12 months.

HIND's Profit vs Risk Rating (100) in the null industry is in the same range as PHAT (100). This means that HIND’s stock grew similarly to PHAT’s over the last 12 months.

HIND's SMR Rating (100) in the null industry is in the same range as PHAT (100). This means that HIND’s stock grew similarly to PHAT’s over the last 12 months.

HIND's Price Growth Rating (77) in the null industry is in the same range as PHAT (84). This means that HIND’s stock grew similarly to PHAT’s over the last 12 months.

HIND's P/E Growth Rating (100) in the null industry is in the same range as PHAT (100). This means that HIND’s stock grew similarly to PHAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HINDPHAT
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (HIND: $1.90 vs. PHAT: $7.50)
Brand notoriety: HIND and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HIND: 120% vs. PHAT: 77%
Market capitalization -- HIND: $14.25M vs. PHAT: $594.62M
HIND [@Biotechnology] is valued at $14.25M. PHAT’s [@Biotechnology] market capitalization is $594.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HIND’s FA Score shows that 0 FA rating(s) are green while PHAT’s FA Score has 0 green FA rating(s).

  • HIND’s FA Score: 0 green, 5 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, HIND is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HIND’s TA Score shows that 3 TA indicator(s) are bullish while PHAT’s TA Score has 6 bullish TA indicator(s).

  • HIND’s TA Score: 3 bullish, 5 bearish.
  • PHAT’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than HIND.

Price Growth

HIND (@Biotechnology) experienced а -5.47% price change this week, while PHAT (@Biotechnology) price change was +5.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.28%. For the same industry, the average monthly price growth was -17.87%, and the average quarterly price growth was -21.14%.

Reported Earning Dates

HIND is expected to report earnings on Nov 24, 2026.

PHAT is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-10.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
HIND
Daily Signal:
Gain/Loss:
PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYF5.120.27
+5.57%
X Financial
KBDC12.630.23
+1.85%
Kayne Anderson BDC Inc.
SUNB76.510.90
+1.19%
Sunbelt Rentals Holdings Inc.
ZDAI1.30-0.02
-1.52%
DirectBooking Technology Co. Ltd.
SEB3971.81-62.01
-1.54%
Seaboard Corp

HIND and

Correlation & Price change

A.I.dvisor indicates that over the last year, HIND has been loosely correlated with IMMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIND
1D Price
Change %
HIND100%
N/A
IMMP - HIND
36%
Loosely correlated
-5.03%
GUTS - HIND
33%
Loosely correlated
+1.96%
CABA - HIND
31%
Poorly correlated
-4.32%
CLDX - HIND
31%
Poorly correlated
+3.93%
PHAT - HIND
30%
Poorly correlated
+1.35%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with ALNY. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+1.35%
ALNY - PHAT
45%
Loosely correlated
+4.26%
QCLS - PHAT
39%
Loosely correlated
+3.32%
ATRA - PHAT
36%
Loosely correlated
+0.94%
KURA - PHAT
31%
Poorly correlated
+0.94%
RAPP - PHAT
31%
Poorly correlated
+4.38%
More